Cingulate Inc —— 资产负债表 (NASDAQ:CING)

Financials

总资产 22.89 M11.41 M3.49 M14.86 M15.07 M 负债总额 2.04 M7.52 M10.36 M7.41 M12.56 M 权益总额 20.84 M3.88 M-6.87 M7.46 M2.51 M 负债及股东权益总额 22.89 M11.41 M3.49 M14.86 M15.07 M 总债务 1.12 M5.83 M2.59 M4.97 M7.45 M 净债务 -15.37 M472.23 K2.54 M-7.24 M-3.51 M

新闻

Cingulate将场外发行上限提高至3190万美元

Cingulate increases at-the-market offering limit to $31.9 million

Cingulate重新任命Shane Schaffer为首席执行官，更新雇佣条款

Cingulate reinstates Shane Schaffer as CEO, updates employment terms

Cingulate appoints new CCO, secures $6 million financing

Cingulate’s ADHD drug meets primary endpoints in phase 3 trial

FDA接受Cingulate的ADHD药物申请，设定2026年5月目标日期

FDA accepts Cingulate’s ADHD drug application, sets May 2026 target date

Cingulate与Bend Bio Sciences达成ADHD药物生产协议

Cingulate secures manufacturing deal with Bend Bio Sciences for ADHD drug

Cingulate issues shares to lender in series of unregistered transactions

Cingulate appoints John A. Roberts as executive chairman, CEO placed on leave